Between 2024 and 2028, hospital discharges for malignant neoplasm of ovary in Germany are projected to decline from 61.1 to 56.9 units per hundred thousand persons. The year-on-year change shows a consistent decline: 1.8% from 2024 to 2025, 1.7% from 2025 to 2026, and 1.9% from 2026 to 2027, followed by a 1.7% decrease to 2028. The compound annual growth rate (CAGR) over these years is approximately -1.8%, indicating a persistent downward trend. In 2023, the value stood slightly higher than in 2024, highlighting a declining pattern before the forecasted period.
Trends to watch for in the future include advancements in early detection and treatment of ovarian cancer, which could drive further reductions in hospital discharges. Additionally, public health campaigns and preventative measures could also contribute to this decline.
